IRDA issues IPO guidelines for life insurers

MUMBAI Thu Dec 1, 2011 8:10pm IST

A man shows balloons in the colours of the Indian flag to his child at a market during Independence Day celebrations in Chandigarh August 15, 2008. REUTERS/Ajay Verma/Files

A man shows balloons in the colours of the Indian flag to his child at a market during Independence Day celebrations in Chandigarh August 15, 2008.

Credit: Reuters/Ajay Verma/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - The Insurance Regulatory and Development Authority (IRDA) on Thursday notified guidelines for life insurers to raise capital via initial public offering or subsequent public fund raising from the equity markets.

The IRDA has stipulated that life insurance firms must be operating for at least 10 years before planning such fund raising.

The firms must first obtain IRDA's nod before seeking the approval of the capital markets regulator, the Securities and Exchange Board of India, IRDA said in a document posted on its website.

The IRDA's approval will be valid for a year and insurers will need to file initial papers for their public issues with SEBI within that period.

India, which opened up its insurance sector to private and foreign players in 2000, caps foreign holding at 26 percent in these companies.

Life insurance penetration in India is about 4 percent of the gross domestic product, in terms of total premiums underwritten in a year, compared with 2.4 percent in China and about 13.5 percent in Britain.

Industry executives have said the outlook for the business remains bright in an under-insured country of more than a billion people.

State-owned Life Insurance Corporation of India was once the only option for the world's second-most populous country.

Now, two dozen players including ICICI Prudential Life Insurance, HDFC Standard Life Insurance, Aviva Life Insurance Company and Bajaj Allianz Life Insurance vie for a bigger share of the insurance market in India and most of these are in joint venture with foreign partners.

(Reporting by Ketan Bondre; editing by Malini Menon)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

 G20 Meet

G20 Meet

As G20 chases growth goal, members differ on how to get there   Full Article 

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Alibaba Listing

Alibaba Listing

Alibaba surges on massive demand in trading debut  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Apple Not Cool?

Apple Not Cool?

Some consumers say Apple is losing its "cool" factor  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage